FDA Inspection 1094745 — Jiangsu Hansoh Pharmaceutical Group Co., Ltd
The FDA completed an inspection of Jiangsu Hansoh Pharmaceutical Group Co., Ltd on June 13, 2019 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)